Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (abre una nueva ventana)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Fuente‎: Eur J Haematol 1996;56(5):326-8.

Indexado en‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (abre una nueva ventana)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (abre una nueva ventana)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Fuente‎: Acta Haematol 1995;94(3):128-34.

Indexado en‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (abre una nueva ventana)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (abre una nueva ventana)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Fuente‎: Haematologica 2006;91(8):1076-83.

Indexado en‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (abre una nueva ventana)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (abre una nueva ventana)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Fuente‎: J Obstet Gynaecol 2007;27(1):82-3.

Indexado en‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (abre una nueva ventana)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (abre una nueva ventana)

Wang SW, Badami CD, Deitch EA.

Fuente‎: Am Surg 2009;75(12):1175-8.

Indexado en‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (abre una nueva ventana)